Shanghai Sanyou Medical Co., Ltd (SHA:688085)

Market Cap	4.55B -20.1%
Revenue (ttm)	549.93M +13.7%
Net Income	57.33M +117.3%
EPS	0.17 +94.0%
Shares Out	366.81M
PE Ratio	73.62
Forward PE	40.69
Dividend	0.02 (0.14%)
Ex-Dividend Date	Jun 11, 2026

Volume	2,290,071
Open	12.30
Previous Close	13.65
Day's Range	12.01 - 12.43
52-Week Range	12.04 - 26.13
Beta	-0.00
Analysts	Buy
Price Target	35.81 (+194.73%)
Earnings Date	Aug 26, 2026

About Shanghai Sanyou Medical

Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and minimally invasive products; and trauma implants, including shoulder and elbow system, hip and pelvis system, knee joint system, foot and ankle, and palm and wrist systems. It also offers sports medicine. Shanghai Sanyou Medical Co., Lt...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 514
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688085

Financial Performance

In 2025, Shanghai Sanyou Medical's revenue was 542.79 million, an increase of 19.66% compared to the previous year's 453.60 million. Earnings were 63.10 million, an increase of 450.20%.